References
- Papoff P, Cerasaro C, Caresta E, et al. Current strategies for treating infants with severe bronchopulmonary dysplasia. J Matern Fetal Neonatal Med 2012;25:15–20
- Greenough A. Long term respiratory outcome of very premature birth (<32 weeks). Semin Fetal Neonatal Med 2012;17:73–6
- Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 2006;30:227–32
- Gough A, Spence D, Linden M, et al. General and respiratory outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. Chest 2012;141:1554–67
- Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995;152:640–6
- Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710–17
- Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm infants. Am J Respir Crit Care Med 1999;159:945–58
- Abman SH. Bronchopulmonary dysplasia: “a vascular hypothesis”. Am J Respir Crit Care Med 2001;164:1755–6
- Ladha F, Bonnet S, Eaton F, et al. Sildenafil improves alveolar growth und pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 2005;172:750–6
- de Visser YP, Walther FJ, Laghmani el H, et al. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res 2009;10:30
- Baquero H, Soliz A, Neira F, et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006;117:1077–83
- Steinhorn RH, Kinsella JP, Pierce C, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009;155:841–47.e1
- Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009;154:379–84, 384.e1–2
- Nyp M, Sandritter T, Poppinga N, et al. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange, any benefits? J Perinatol 2012;32:64–9
- Skinner JR, Stuart AG, O’Sullivan J, et al. Right heart pressure determination by Doppler in infants with tricuspid regurgitation. Arch Dis Child 1993;69:216–20
- Ballard RA, Truog WE, Cnaan A, et al; NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. New Engl J Med 2006;355:343–53
- Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993–2006. Pediatrics 2010;126:291–7
- Hon KL, Cheung KL, Siu KL, et al. Oral sildenafil for treatment of severe pulmonary hypertension in an infant. Biol Neonate 2005;88:109–12
- Juliana AE, Abbad FC. Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 2005;164:626–9
- Simiyu DE, Okello C, Nyakundi EG, Tawakal AH. Sildenafil in management of persistent pulmonary hypertension of the newborn: report of two cases. East Afr Med J 2006;83:337–40
- Ahsman MJ, Witjes BC, Wildschut ED, et al. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed 2010;95:109–14
- O’Reilly M, Hooper SB, Allison BJ, et al. Persistent bronchiolar remodeling following brief ventilation of the very immature ovine lung. Am J Physiol Lung Cell Mol Physiol 2009;297:L992–1001
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9
- Van Meurs KP, Wright LL, Ehrenkranz RA, et al; Preemie Inhaled Nitric Oxide Study. Inhaled nitric oxide for premature infants with severe respiratory failure. New Engl J Med 2005;353:13–22
- Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. New Engl J Med 2006;355:354–64
- Mercier JC, Hummler H, Durrmeyer X, et al. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet 2010;376:346–54
- Askie LM, Ballard RA, Cutter GR, et al. Meta-analysis of preterm patients on inhaled nitric oxide collaboration. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics 2011;128:729–39
- Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naïve children with pulmonary arterial hypertension. Circulation 2012;125:324–34
- FDA Drug Safety Communication: FDA recommends against use of Revatio in children with pulmonary hypertension. Available from http://www.fda.gov/Drugs/DrugSafety/ucm317123.htm [last accessed 16 October 2012]